Product Code: PM3843
The global hemianopsia market size is expected to reach USD 676.29 million by 2032, according to a new study by Polaris market research. The report "Hemianopsia Market Share, Size, Trends, Industry Analysis Report, By Type (Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia); By Treatment; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing awareness among healthcare professionals, patients, and the general public about visual impairments, including hemianopsia, leading demand for early diagnosis and appropriate treatment, along with the investment in research and clinical trials helping validate the efficacy of new treatments and diagnosis, are prominent factors propelling the overall market growth.
The rapid development of diagnostic tools, such as advanced imaging techniques and visual field-testing methods, that results in improving accuracy and efficiency in diagnosing hemianopsia and innovations in neuro-rehabilitation therapies, which include virtual reality, computer-based training, and neuro-stimulation techniques, has also been among the factors creating lucrative growth opportunities for the market. For instance, in April 2023, Sensoria Health announced the launch of its new wearable system named NeurOpTrek, powered by Sensoria, which is designed to improve vision and help to reduce the risk of falls, a serious health concern mainly for older adults.
The surging technology integration across various types of devices and systems, including wearable devices, virtual reality systems, mobile applications, and computer-based training programs, mainly to assist individuals with hemianopsia in various aspects of their daily lives and the ability of these technologies to compensate for visual field deficits, enhance functional vision, and support independence and quality of life, are among the most emerging trends in the global market.
Additionally, there has been a growing emphasis on neuroplasticity and rehabilitation approaches in the treatment of hemianopsia in recent years, and a surging number of researchers and clinicians are exploring techniques that promote cortical reorganization and functional recovery of the visual field through targeted training coupled with the proliferation for awareness campaigns, educational materials, and conferences, contributing to improved recognition and management of hemianopsia all over the world.
Hemianopsia Market Report Highlights
Homonymous hemianopsia segment accounted for largest global market share in 2022, owing to increasing prevalence of diseases as common visual impairment due to different causes including tumors and stroke
Vision restoration therapy segment held the maximum market revenue share in 2022, which is mainly driven by rising number of regulatory agencies recognizing the importance of these therapies
Specialty clinics segment is projected to emerge as fastest growing region with a significant CAGR over the study period, due to rising incorporation of advanced novel therapies
North America region led the industry market with substantial share in 2022, on account of robust presence of developed healthcare infrastructure and number of surgeries being performed across the region
The global key market players include: F. Hoffman-La Roche, Novartis AG, Aerie Pharmaceuticals, AkzoNobel N.V., AbbVie Inc., EyeTech Digital Systems, and NeuroVision Imaging LLC
Polaris market research has segmented the Hemianopsia market report based on type, treatment, end user, and region:
Hemianopsia, Type Outlook (Revenue - USD Million, 2019 - 2032)
- Homonymous Hemianopsia
- Quadrantanopsia
- Bitemporal Hemianopsia
Hemianopsia, Treatment Outlook (Revenue - USD Million, 2019 - 2032)
- Vision Restoration Therapy
- Visual Field Expander Aid
Hemianopsia, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Specialty Clinics
Hemianopsia, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hemianopsia Market Insights
- 4.1. Hemianopsia Market - End User Snapshot
- 4.2. Hemianopsia Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological Advancement
- 4.2.1.2. Increasing Incidence of Brain Injuries
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Treatment Costs
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hemianopsia Market End User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hemianopsia Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 5.3. Homonymous Hemianopsia
- 5.3.1. Global Hemianopsia Market, by Homonymous Hemianopsia, by Region, 2019-2032 (USD Million)
- 5.4. Quadrantanopsia
- 5.4.1. Global Hemianopsia Market, by Quadrantanopsia, by Region, 2019-2032 (USD Million)
- 5.5. Bitemporal Hemianopsia
- 5.5.1. Global Hemianopsia Market, by Bitemporal Hemianopsia, by Region, 2019-2032 (USD Million)
6. Global Hemianopsia Market, by Treatment
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 6.3. Vision Restoration Therapy
- 6.3.1. Global Hemianopsia Market, by Vision Restoration Therapy, by Region, 2019-2032 (USD Million)
- 6.4. Visual Field Expander Aid
- 6.4.1. Global Hemianopsia Market, by Visual Field Expander Aid, by Region, 2019-2032 (USD Million)
7. Global Hemianopsia Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Hemianopsia Market, by Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Specialty Clinics
- 7.4.1. Global Hemianopsia Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)
8. Global Hemianopsia Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Hemianopsia Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Hemianopsia Market - North America
- 8.3.1. North America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.3.2. North America: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.3.3. North America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.3.4. Hemianopsia Market - U.S.
- 8.3.4.1. U.S.: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.3.5. Hemianopsia Market - Canada
- 8.3.5.1. Canada: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4. Hemianopsia Market - Europe
- 8.4.1. Europe: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.3. Europe: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.4. Hemianopsia Market - UK
- 8.4.4.1. UK: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.4.3. UK: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.5. Hemianopsia Market - France
- 8.4.5.1. France: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.5.3. France: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.6. Hemianopsia Market - Germany
- 8.4.6.1. Germany: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.7. Hemianopsia Market - Italy
- 8.4.7.1. Italy: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.8. Hemianopsia Market - Spain
- 8.4.8.1. Spain: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.9. Hemianopsia Market - Netherlands
- 8.4.9.1. Netherlands: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.4.10. Hemianopsia Market - Russia
- 8.4.10.1. Russia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5. Hemianopsia Market - Asia Pacific
- 8.5.1. Asia Pacific: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.4. Hemianopsia Market - China
- 8.5.4.1. China: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.4.3. China: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.5. Hemianopsia Market - India
- 8.5.5.1. India: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.5.3. India: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.6. Hemianopsia Market - Malaysia
- 8.5.6.1. Malaysia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.7. Hemianopsia Market - Japan
- 8.5.7.1. Japan: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.8. Hemianopsia Market - Indonesia
- 8.5.8.1. Indonesia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.5.9. Hemianopsia Market - South Korea
- 8.5.9.1. South Korea: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.6. Hemianopsia Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.6.4. Hemianopsia Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.6.5. Hemianopsia Market - UAE
- 8.6.5.1. UAE: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.6.6. Hemianopsia Market - Israel
- 8.6.6.1. Israel: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.6.7. Hemianopsia Market - South Africa
- 8.6.7.1. South Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.7. Hemianopsia Market - Latin America
- 8.7.1. Latin America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.7.4. Hemianopsia Market - Mexico
- 8.7.4.1. Mexico: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.7.5. Hemianopsia Market - Brazil
- 8.7.5.1. Brazil: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
- 8.7.6. Hemianopsia Market - Argentina
- 8.7.6.1. Argentina: Hemianopsia Market, by Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AbbVie Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Aerie Pharmaceuticals Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3.AkzoNobel N.V.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Carl Zeiss AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Chadwick Optical
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. EyeTech Digital Systems
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Genetech Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Healio
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. LumiThera Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. NeuroVision Imaging LLC
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Novartis AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. NovaVision
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. RetroSense Therapeutics LLC
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Samsung Medical Center
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. VisionCare Inc.
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Vycor Medical Inc.
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development